The University of Texas MD Anderson Cancer Center was awarded $2.5 million today from the Cancer Prevention and Research Institute of Texas (CPRIT) to support cancer research projects across the institution. Four of the five grants awarded to MD Anderson today are CPRIT High-Impact/High-Risk Research Awards, which provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment or prevention of cancers. “We are […]
Cancer Center
Focus Fund And Md Anderson Launch Investment Fund To Support Promising Investigational Cancer Therapies In Early-Stage Clinical Trials
Combination of over $50 million in committed capital along with access to cancer expertise and clinical facilities will help advance novel IND-ready candidates The Focus Fund GP, LLC, in partnership with The University of Texas MD Anderson Cancer Center, has launched Cancer Focus Fund, LP, an oncology-focused investment fund designed to support the advancement of compelling investigational cancer therapies from late preclinical development through Phase I and Phase Ib/II clinical trials. Small to midsize biopharmaceutical companies often […]